AAAAI reinforces adverse allergic reaction to the vaccines is rare and mild when it does occur and should not deter individuals from being vaccinated.

MILWAUKEE (PRWEB) November 08, 2021

While individuals with a history of severe allergy are at higher risk for a reaction to the COVID-19 vaccine, those reactions are rare and should not preclude someone from getting vaccinated, recent studies show.

"The rate of anaphylaxis after the vaccine remains low and is readily treatable. The reactions that do occur, are mild, uncommon and do not interfere with receiving the vaccine," said Paul Williams, MD, FAAAAI, Emeritus Director with the Northwest Asthma and Allergy Center and Chair of the American Academy of Allergy, Asthma & Immunology (AAAAI) COVID-19 Response Task Force. "People with a confirmed history of an allergy to a component of one vaccine can receive another vaccine that does not contain that component."

Allergists are specifically trained to help people answer questions about vaccine safety and suggest approaches to vaccination that would be the safest for patients.

To speak with Dr. Williams or another allergy expert, please contact: media@aaaai.org.

The American Academy of Allergy, Asthma & Immunology also has a wealth of resources available on its COVID-19 Resources page.

Recent research on allergy and the COVID-19 vaccines:

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

For the original version on PRWeb visit: https://www.prweb.com/releases/allergic_reactions_to_covid_vaccines_rare_and_do_not_preclude_immunization/prweb18319898.htm

Link:
Allergic Reactions to COVID Vaccines Rare and Do Not Preclude Immunization - Benzinga - Benzinga